Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Eminent Spine Posterior SI System

K-Number: K250894 · 2025-10-07

ApplicantEminent Spine
Decision Date2025-10-07
Product CodeOUR
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Eminent Spine Posterior SI System is the device name listed in this FDA 510(k) record. The listed applicant is Eminent Spine. It received FDA 510(k) clearance on 2025-10-07 under 510(k) number K250894. The device is classified under product code OUR. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Eminent Spine Posterior SI System?

Eminent Spine Posterior SI System is a medical device that received FDA 510(k) clearance on 2025-10-07. The listed applicant is Eminent Spine. The 510(k) number is K250894.

When did Eminent Spine Posterior SI System receive FDA 510(k) clearance?

Eminent Spine Posterior SI System received FDA 510(k) clearance on 2025-10-07, under 510(k) number K250894.

Who is the listed applicant for Eminent Spine Posterior SI System?

The FDA 510(k) record lists Eminent Spine as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Eminent Spine Posterior SI System?

The FDA product code for Eminent Spine Posterior SI System is OUR.

Other records listing Eminent Spine as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 9 devices →

Related Devices (Code: OUR)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.